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Abstract 
Purpose: To develop and validate an accurate, rapid and reproducible reversed-phase high 
performance liquid chromatography (RP-HPLC) analytical method for the lipid lowering drug, 
simvastatin, and to apply the developed method to study the solubility of the drug in various oils and 
surfactants.  
Methods: Isocratic RP-HPLC system with a UV-vis detector, and a column with dimensions 4.6 mm x 
150 mm and 5µ particle size, was employed. The mobile phase consisted of methanol and 0.01M 
KH2PO4 phosphate buffer (80:20) at pH 5.5 adjusted with phosphoric acid (2M) and pumped at a flow 
rate of 1 ml/min. Validation parameters, viz, limit of detection (LOD), limit of quantification (LOQ) 
linearity, accuracy, precision, and sensitivity, were established. Solubility study was performed in 
various oils and surfactants at 25 °C and the developed HPLC method was applied to analyze all 
samples. 
Results: The developed HPLC method showed good linearity (R2 = 0.9958 ± 0.0040. The intra- and 
inter-day % accuracy was more than 98 %. LOQ and LOQ were 0.160 and 0.484 μg/ml respectively. 
Simvastatin showed the highest solubility in sesame oil (15 mg/ml) and in Tween 80 (11 mg/ml) at 25 
oC. 
Conclusion: An accurate, rapid and robust HPLC-UV method has been developed, validated and 
applied successfully to determine the solubility of simvastatin in oils. 
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that belongs to the statin drug family; the 
members of which are used as cholesterol-
lowering agents for patients with 
hypercholesterolemia. This semi synthetic drug 
exhibits a very important hepatic first-pass 
metabolism by inhibiting 3-hydroxy- 3-
methylglutaryl coenzyme-A reductase (HMG-
CoA) and reduces low-density lipoproteins [1,2]. 
Structure of simvastatin has been shown in 
Figure 1. 
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Figure 1: Structure of simvastatin 
 
Various methods such as HPTLC [3], 
electrokinetic chromatography and voltametry [4] 
have been reported. Based on different 
techniques several methods like high 
performance liquid chromatography/mass 
spectrometry (LC/MS) [5-9], Gas 
chromatography/mass spectrometry (GC/MS) 
[10], high performance liquid chromatography 
(HPLC) [11-14] and high performance thin layer 
chromatography (HPTLC) [15] have been 
developed but these methods utilize expensive 
reagents or buffers as the mobile phase or 
complex procedures adopted in sample 
preparation.  
 
Therefore, the aim of this study was to develop a 
simple and rapid HPLC-UV method to investigate 
the solubility of simvastatin in various oils and 
surfactants. The study focus was to explore the 





Chemicals and reagents 
 
Simvastatin was received as a gift from Sami 
Pharmaceutical (Pvt) Ltd Karachi, Pakistan. All 





HPLC system of Sykam S 3210 consisted of 
isocratic pump (Sykam GmbH HPLC system, 
Germany) with UV-Detector (Sykam UV/VIS 
Germany), column (with dimensions of 4.6 mm x 
150 mm, 5µ particle size) and computer software 
(Clarity operating software) with Microsoft 
Windows XP Professional, ultrasonic bath 
(Fisher Scientific FS 28 H (Germany), centrifuge 
machine (model 4000 (China), column 
thermostat (Sykam 4011, Thermo controller, 
Germany), injection syringe (20 µl, Rheodyne 
Injector, Germany), magnetic stirrer 
(Gallenkamp, England), membrane filter 
(Sartorius, 0.45 μm pore size, Germany). 
 
Preparation of standard solutions 
 
The stock standard solution of simvastatin was 
prepared by dissolving the accurately weighed 
simvastatin in Methanol. The stock standard 
solutions were then diluted with methanol to 
achieve standard working solutions at 
concentrations of 0.612, 1.25, 2.5, 5, 10, 20, 40, 




To construct a calibration curve, standard stock 
solution of simvastatin was diluted to give 
concentrations of 2.5, 5, 10, 20, 40, 80, 160, 320 
and 640 µg/ml. Separate labeled glass centrifuge 
tubes were used for all the dilutions. 
Chromatograms for these concentrations were 
obtained by injecting 20 µl of standard solutions. 
Regression analysis was carried out. A typical 




Figure 2: Representative chromatogram of ibuprofen 
(internal standard) and simvastatin 
 
High performance liquid chromatography 
 
An isocratic pump with flow rate of 1ml/min and 
UV-detector set at a wavelength of 238nm, 
column (with dimensions of 4.6 mm x 250 mm 5µ 
particle size) and Clarity software for data 
analysis were employed. The mobile phase 
consisted of methanol and 0.01M KH2PO4 
phosphate buffer (80:20) and pH was maintained 




Linearity of the assay method was determined by 
constructing calibration curve to find out the 
relationship between instrument response and 
known concentrations of the analytes. The 
number of standards used in constructing a 
calibration curve was selected to the anticipated 
range of analytical values of simvastatin in the 
samples of interest. Each drug concentration in 
three replicates was run in the HPLC system 
(Sykam S 3210 series) and the data plotted to 
determine the parameters of standard curve. 
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Determination of precision and accuracy 
 
The accuracy of an analytical method describes 
the closeness of mean test results obtained by 
true value (concentration) of the analyte. 
Accuracy was determined by triplicate based on 
analysis of low, medium and high concentrations 
of samples containing known amounts of the 
analyte. Accuracy in present method was 
measured by using a minimum of three 
concentrations in the range of expected 
concentrations (intra-day). The deviation of mean 
from the true value served as the measure of 
accuracy. The precision of an analytical method 
describes the closeness of individual measures 
of an analyte when the procedure is applied 
repeatedly to multiple aliquots of a single 
homogenous volume of biological fluid (inter-
day). Precision was measured in triplicate at 
three concentrations in the range of expected 
concentrations.  
 
Assessment of quantification limits 
 
LOD and LOQ values were calculated by 
injecting the solutions with known decreased 
concentrations of simvastatin into the HPLC 
system. The limit of detection (LOD) and 
quantification (LOQ) were then measured by 
calculating the minimum level at which the 
simvastatin can be readily detected (signal to 
noise ratio of 3:1) and quantified (signal to noise 
ratio of 10:1). 
 
Application of method 
 
The developed HPLC-UV method was applied to 
determine the solubility of simvastatin in various 
oils (canola oil, sesame oil, sunflower oil, oleic 
acid, olive oil, arachis oil and soybean oil),  
surfactants (Tweens 20 and 80, and Span 85), 
and co-surfactants (propylene glycol and 
polyethylene glycol 400). An excess amount of 
simvastatin was added to separate capped glass 
vials containing 2 ml of each of the vehicles. 
After sealing, the mixture was heated at 40 °C in 
a water-bath to facilitate solubilization using a 
vortex mixer. The mixtures were shaken in a 
shaker apparatus at 25 °C for 48 h. After 
reaching equilibrium, each vial was centrifuged at 
4000 rpm for 10 min, filtered using a membrane 
filter (0.45 μ, 13 mm, Whatman, USA) and the 
filtrate suitably diluted prior to injecting into the 
chromatograph. The concentration of simvastatin 




Calibration curve parameters of simvastatin have 
been shown in Figure 2. Mean correlation 
coefficient (R2) slope and intercept values were 
obtained as 0.9958, 228.5 and 45.145 
respectively. The developed method showed 
good linearity with mean correlation coefficient of 
0.9958 ± 0.004. Limits of quantitation (LOQ) and 
of detection (LOD) of simvastatin were 0.160 and 
0.484 μg/ml, respectively. Percent coefficient of 
variation (CV%) for both intra- and inter-day was 
< 2 % which is well within the range of 15 % for 
lowest and 20 % for highest concentration based 
on FDA criteria for biological fluids [16]. Intra-day 
and Inter-day accuracy and precision are shown 
in Table 1. 
 




   LQC   MQC HQC 
  5 μg/mL   25 μg/mL 50 μg/mL 
Intra-day 
Batch-01 4.97 24.8 49.88 
 4.98 24.75 49.52 
 4.89 24.62 49.48 
Batch-02 4.87 24.72 49.67 
 4.93 24.82 49.76 
 4.87 24.76 49.69 
Batch-03 4.98 24.98 49.98 
 5.00 24.75 49.96 
 4.97 24.80 49.97 
   Mean 4.94 24.78 49.77 
S.D. 0.05 0.10 0.19 
% CV 1.04 0.39 0.39 
% accuracy 98.80 99.11 99.54 
Inter-day 
Batch 01 4.97 24.97 49.96 
Batch 02 4.98 24.88 49.78 
Batch 03 4.96 24.78 49.98 
Batch 04 5.01 24.75 49.95 
Batch 05 4.98 24.98 49.84 
Batch 06 4.88 24.77 49.97 
   Mean 4.96 24.86 49.91 
S.D. 0.04 0.10 0.08 
% CV 0.89 0.42 0.17 
% accuracy 99.27 99.42 99.83 
 
The proposed method was applied to assess the 
solubility profile of simvastatin in various oils and 
surfactants. Simvastatin showed the highest 
solubility in sesame oil and (15 mg/ml) and was 
more soluble in this oil than in Tween 80 (11 
mg/ml). The solubility profile of simvastatin in 
various media, mainly oils and surfactants, is 
shown in Table 2.  
 
In the development process, different 
compositions of mobile phase with several 
combinations of buffer and organic phases, 
including acetonitrile, methanol and buffer in 
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varying ratios, were tested. The mobile phase, 
consisting of KH2PO4 and methanol in the ratio of 
20:80 (%v/v) and with a pH of 5.5 was chosen. 
This mobile phase was found to be suitable to 
achieve the desired objectives of not absorbing 
at low wavelength and sufficient in concentration 
to avoid peak tailing since silica-based particles 
are unstable at low pH (< 2).  
 
Table 2: Solubility of simvastatin in various media 
 
Medium Solubility  
(mg/mL) 
Propylene glycol 4.930 
Canola oil 2.257 
Sesame oil 14.986 
Sunflower oil 1.228 
Oleic acid 1.033 
Tween 20 9.172 
Olive oil 4.556 
Span 85 6.486 
Arachis oil 2.035 
Soya been oil 1.745 
Tween 80 11.139 




Flow rate of 1.0ml/min. was found appropriate for 
peak resolution with a short retention time. 
Similarly, different stationary phases of suitable 
dimensions were also tried to achieve retention 
and separation. The run time was short requiring 
only 15 min While the retention time for 
simvastatin was 8.5 min.  
 
The higher solubility of simvastatin in sesame oil 
and than in Tween 80 is noteworthy. The results 
suggest that both of these media can be utilized 
to prepare lipid-based delivery systems to 
enhance the solubility of simvastatin and thus 




The findings of this study are significant two 
major ways, First, an accurate, reproducible and 
rapid analytical method utilizing commonly 
available chemicals and technique was 
successfully developed and validated. Second, 
the solubility data generated for simvastatin in 
various various media could be helpful in 
formulating lipid-based formulation of the drug to 
enhance its solubility of this poorly soluble agent. 
It is seems feasible therefore that micro-
emulsions of simvastatin can be developed to 
improve bioavailability based on the solubility 
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